Jiangsu Aoyang Health Industry Co.ltd.
SZSE:002172.SZ
3.63 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,009.775 | 2,173.768 | 2,021.311 | 3,028.919 | 3,083.401 | 2,982.035 | 4,710.673 | 5,366.49 | 4,875.818 | 3,808.779 | 2,931.164 | 3,277.44 | 3,552.362 | 3,823.993 | 3,805.269 | 2,340.466 | 1,634.642 | 2,087.321 | 1,320.959 | 985.574 | 789.668 |
| Cost of Revenue
| 1,740.737 | 1,884.709 | 1,739.545 | 2,801.229 | 3,067.948 | 2,782.609 | 4,325.189 | 4,776.363 | 4,237.881 | 3,284.153 | 2,717.06 | 2,893.988 | 3,307.036 | 3,934.243 | 3,352.292 | 1,848.122 | 1,678.33 | 1,480.192 | 1,036.657 | 785.485 | 635.561 |
| Gross Profit
| 269.038 | 289.058 | 281.767 | 227.69 | 15.454 | 199.426 | 385.484 | 590.127 | 637.937 | 524.625 | 214.104 | 383.452 | 245.326 | -110.25 | 452.977 | 492.344 | -43.688 | 607.13 | 284.301 | 200.089 | 154.107 |
| Gross Profit Ratio
| 0.134 | 0.133 | 0.139 | 0.075 | 0.005 | 0.067 | 0.082 | 0.11 | 0.131 | 0.138 | 0.073 | 0.117 | 0.069 | -0.029 | 0.119 | 0.21 | -0.027 | 0.291 | 0.215 | 0.203 | 0.195 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 1.27 | 20.85 | 57.388 | 5.595 | 2.329 | 2.319 | 2.593 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 27.178 | 45.974 | 42.978 | 129.121 | 115.939 | 238.676 | 78.562 | 64.51 | 45.347 | 106.701 | 44.723 | 33.01 | 38.801 | 64.24 | 61.196 | 88.538 | 106.643 | 73.661 | 39.635 | 32.335 | 27.987 |
| Selling & Marketing Expenses
| 18.789 | 49.931 | 46.219 | 53.489 | 55.606 | 91.978 | 111.598 | 133.012 | 129.459 | 96.679 | 140.356 | 148.619 | 126.71 | 157.296 | 122.889 | 107.284 | 73.851 | 75.112 | 67.765 | 41.839 | 22.152 |
| SG&A
| 45.968 | 95.905 | 89.197 | 182.611 | 171.545 | 330.654 | 190.161 | 197.523 | 174.806 | 203.38 | 185.079 | 181.629 | 165.511 | 221.537 | 184.084 | 195.822 | 180.494 | 148.773 | 107.4 | 74.174 | 50.139 |
| Other Expenses
| 155.462 | 111.167 | 118.408 | 190.987 | 132.078 | 170.367 | 94.957 | 45.64 | 56.391 | 46.545 | 8.563 | 25.209 | 124.546 | 13.567 | 14.057 | 21.004 | 83.669 | 2.883 | -0.772 | 1.676 | -0.102 |
| Operating Expenses
| 201.429 | 207.072 | 207.605 | 373.598 | 304.892 | 521.87 | 391.029 | 387.976 | 341.332 | 337.089 | 250.793 | 249.197 | 245.262 | 286.116 | 245.768 | 201.012 | 183.606 | 158.496 | 112.462 | 78.189 | 53.37 |
| Operating Income
| 67.609 | 81.986 | 46.573 | -147.25 | -272.57 | -322.444 | -101.58 | 137.91 | 238.671 | 70.068 | -139.294 | -2.65 | -82.511 | -812.472 | 119.511 | 237.34 | -396.067 | 405.671 | 149.634 | 106.407 | 90.998 |
| Operating Income Ratio
| 0.034 | 0.038 | 0.023 | -0.049 | -0.088 | -0.108 | -0.022 | 0.026 | 0.049 | 0.018 | -0.048 | -0.001 | -0.023 | -0.212 | 0.031 | 0.101 | -0.242 | 0.194 | 0.113 | 0.108 | 0.115 |
| Total Other Income Expenses Net
| -2.433 | -12.042 | -47.538 | 18.738 | -1.536 | -232.69 | 94.957 | 33.933 | 51.165 | 46.365 | -31.278 | -75.993 | 124.424 | -63.946 | -61.954 | -24.735 | -28.236 | 2.81 | -1.043 | 0.731 | -0.118 |
| Income Before Tax
| 65.176 | 69.944 | -0.964 | -1,078.632 | -438.285 | -555.135 | -6.623 | 183.55 | 294.743 | 116.433 | -131.692 | 22.455 | 41.914 | -799.349 | 133.13 | 258.344 | -368.354 | 408.481 | 148.592 | 107.139 | 90.88 |
| Income Before Tax Ratio
| 0.032 | 0.032 | -0 | -0.356 | -0.142 | -0.186 | -0.001 | 0.034 | 0.06 | 0.031 | -0.045 | 0.007 | 0.012 | -0.209 | 0.035 | 0.11 | -0.225 | 0.196 | 0.112 | 0.109 | 0.115 |
| Income Tax Expense
| 23.935 | 19.681 | 14.793 | -11.433 | 32.94 | 14.085 | 39.668 | 21.671 | 21.319 | 9.68 | 6.899 | -0.098 | 0 | 12.811 | 10.169 | 33.693 | -19.604 | 15.862 | 12.032 | 10.785 | 14.219 |
| Net Income
| 40.562 | 49.682 | -15.757 | -1,067.198 | -471.225 | -569.219 | 10.36 | 154.659 | 259.242 | 135.862 | -104.267 | 20.913 | 35.653 | -695.788 | 100.458 | 161.106 | -278.863 | 216.938 | 86.215 | 58.002 | 59.353 |
| Net Income Ratio
| 0.02 | 0.023 | -0.008 | -0.352 | -0.153 | -0.191 | 0.002 | 0.029 | 0.053 | 0.036 | -0.036 | 0.006 | 0.01 | -0.182 | 0.026 | 0.069 | -0.171 | 0.104 | 0.065 | 0.059 | 0.075 |
| EPS
| 0.053 | 0.06 | -0.021 | -1.39 | -0.62 | -0.74 | 0.01 | 0.21 | 0.38 | 0.2 | -0.16 | 0.04 | 0.06 | -1.25 | 0.19 | 0.46 | -0.53 | 0.66 | 0.22 | 0.3 | 0.3 |
| EPS Diluted
| 0.053 | 0.06 | -0.021 | -1.39 | -0.62 | -0.74 | 0.01 | 0.21 | 0.37 | 0.2 | -0.16 | 0.04 | 0.06 | -1.25 | 0.19 | 0.46 | -0.53 | 0.66 | 0.22 | 0.3 | 0.3 |
| EBITDA
| 171.925 | 185.559 | 168.298 | 73.957 | 25.963 | -205.428 | 328.678 | 496.593 | 548.929 | 466.342 | 177.686 | 312.824 | 388.302 | -565.098 | 331.526 | 400.225 | -265.823 | 489.382 | 208.6 | 152.739 | 120.632 |
| EBITDA Ratio
| 0.086 | 0.085 | 0.083 | 0.024 | 0.008 | -0.069 | 0.07 | 0.093 | 0.113 | 0.122 | 0.061 | 0.095 | 0.109 | -0.148 | 0.087 | 0.171 | -0.163 | 0.234 | 0.158 | 0.155 | 0.153 |